GlassScriptPhysician profile
Michelle Iniguez
NPI 1578103859
$4,003.20
in general payments reported to CMS, 2019-2025
24 companies · $695 in 2025
The $695 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $508 · 2022: $960 · 2023: $1,030 · 2024: $811 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,419 · Education: $87.87 · Travel and Lodging: $28.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,419.39 |
| Education | $87.87 |
| Travel and Lodging | $28.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $973.61 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $751.52 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $417.73 | 2021-2025 | Ofev, Combivent Respimat, Stiolto Respimat |
| Genzyme Corporation | $307.94 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $254.96 | 2022-2025 | Dupixent |
| Mylan Specialty L.P. | $230.02 | 2021-2024 | Yupelri |
| Insmed, INC. | $125.44 | 2021-2025 | Arikayce |
| Inspire Medical Systems, INC. | $112.84 | 2024-2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $107.60 | 2022-2023 | |
| Grifols USA, LLC | $104.64 | 2022-2025 | Prolastin-C Liquid |
| Baxter Healthcare | $93.31 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Amgen INC. | $78.57 | 2022-2025 | Tezspire |
| Viatris Specialty LLC | $72.90 | 2025 | Yupelri |
| Harmony Biosciences LLC | $61.81 | 2022-2023 | Wakix |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $44.57 | 2022 | |
| Electromed, INC. | $38.71 | 2024-2025 | Smartvest |
| Janssen Pharmaceuticals, INC | $31.24 | 2021-2022 | |
| Tactile Systems Technology INC | $29.88 | 2022 | |
| Jazz Pharmaceuticals INC. | $27.15 | 2021 | |
| Inogen, INC. | $20.55 | 2022 | |
| Hikma Pharmaceuticals USA | $14.80 | 2024 | Ryaltris |
| Advanced Respiratory, INC | $13.12 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Iniguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.